Madrigal Pharmaceuticals, Inc. COM is a security (CUSIP 558868105) tracked across SEC portfolio filings. 411 institutional managers reported $12.6B on Form 13F as of 2026-06-30; 43 registered fund positions totaling $743.0M via N-PORT as of 2026-05-31.
Showing 15 of 411 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | NEW YORK, NY | $1.1B | 2,141,701 |
| VANGUARD GROUP INC | Valley Forge, PA | $1.1B | 1,808,894 |
| JANUS HENDERSON GROUP PLC | LONDON, X0 | $1.1B | 2,018,647 |
| RTW INVESTMENTS, LP | NEW YORK, NY | $1.0B | 1,993,687 |
| Avoro Capital Advisors LLC | New York, NY | $951.8M | 1,818,181 |
| BlackRock, Inc. | New York, NY | $816.6M | 1,559,965 |
| PAULSON & CO. INC. | NEW YORK, NY | $728.8M | 1,392,188 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $363.8M | 694,958 |
| STATE STREET CORP | BOSTON, MA | $319.1M | 609,525 |
| CITADEL ADVISORS LLC | MIAMI, FL | $315.4M | 453,843 |
| FMR LLC | BOSTON, MA | $267.9M | 511,728 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $238.7M | 455,870 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | CHICAGO, IL | $178.3M | 340,519 |
| Polar Capital Holdings Plc | London, X0 | $151.4M | 289,310 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $145.2M | 277,371 |
Showing 15 of 43 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD HEALTH CARE FUND | VANGUARD SPECIALIZED FUNDS | $211.6M | 57.40% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $108.8M | 13.35% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $86.9M | 39.93% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $43.7M | 24.93% |
| LORD ABBETT DEVELOPING GROWTH FUND INC | LORD ABBETT DEVELOPING GROWTH FUND, INC. | $42.5M | 191.28% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $39.1M | 35.91% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $36.5M | 28.55% |
| Janus Henderson Venture Fund | JANUS INVESTMENT FUND | $28.5M | 92.91% |
| ACAP Strategic Fund | ACAP Strategic Fund | $20.7M | 20.03% |
| VALUE LINE LARGER COMPANIES FOCUSED FUND, INC. | Value Line Larger Companies Focused Fund, Inc. | $16.8M | 471.06% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $14.6M | 30.17% |
| Columbia Acorn Fund | COLUMBIA ACORN TRUST | $13.8M | 61.67% |
| Advantage Advisers Xanthus Fund, L.L.C. | Advantage Advisers Xanthus Fund, L.L.C. | $11.8M | 39.70% |
| AB DISCOVERY GROWTH FUND, INC. | AB DISCOVERY GROWTH FUND, INC. | $10.7M | 39.89% |
| Fidelity Contrafund | Fidelity Contrafund | $10.3M | 0.65% |